```html

Urachal Anomalies – A Patient‑Friendly Guide

Overview

Urachal anomalies are a group of congenital defects that involve the urachus, a thin tube that connects the fetal bladder to the umbilical cord. After birth the urachus normally closes and becomes a fibrous cord called the median umbilical ligament. When this involution is incomplete, various remnants may persist, leading to cysts, sinuses, fistulas, or a patent (open) urachus.

• Who it affects: Almost all cases are identified in children, but some adults discover a urachal remnant incidentally or when it becomes symptomatic.
• Prevalence: Reported incidence ranges from 0.01% to 0.05% of live births. Urachal carcinoma, a rare malignant transformation, occurs in < 1 % of urachal anomalies and is most common in males aged 40‑60.

Symptoms

Many urachal anomalies are asymptomatic and discovered on imaging for unrelated reasons. When symptoms appear, they depend on the type of anomaly.

Patent Urachus (Urachal Fistula)

• Clear or yellowish discharge from the umbilicus, often worsening when the child cries or strains.
• Wetness or “wet” feeling around the belly button.
• Recurrent umbilical infections (cellulitis, abscess).

Urachal Cyst

• Palpable, painless midline suprapubic mass.
• Occasional localized tenderness.
• Infection → redness, warmth, fever, and possible foul‑smelling discharge if it ruptures.

Urachal Sinus

• Small opening at the umbilicus that may leak clear fluid.
• Recurrent drainage or occasional pain.

Diverticulum (Urachal Pouch)

• Usually silent.
• Can present with lower abdominal pain, urinary frequency, or hematuria if infected.

Urachal Carcinoma (Rare)

• Gross hematuria (blood in urine).
• Painful suprapubic mass.
• Unexplained weight loss, fatigue.

Causes and Risk Factors

Urachal anomalies are congenital; they arise when the urachus fails to close completely during the 5th–7th week of gestation. The exact molecular triggers remain unclear, but several factors have been studied:

• Genetic predisposition: Familial cases are rare, yet some studies suggest associations with mutations affecting embryologic development (e.g., HOX genes) [NIH].
• Male sex: Urachal carcinoma shows a male‑to‑female ratio of ~3:1, possibly reflecting hormonal influences.
• Prematurity: Incomplete fetal maturation may increase the likelihood of a patent urachus.
• Persistent infection or inflammation: Chronic umbilical infections can impede normal closure.

Diagnosis

Because many anomalies are silent, a high index of suspicion is essential when a patient presents with umbilical discharge or an unexplained suprapubic mass.

Clinical Examination

• Inspection of the umbilicus for drainage, redness, or a visible tract.
• Palpation of a midline suprapubic mass.

Imaging Studies

• Ultrasound: First‑line, especially in children; can differentiate cystic from solid lesions and detect fluid tracks.
• CT Scan (Contrast‑enhanced): Provides detailed anatomy, useful for surgical planning or evaluating suspected malignancy.
• MRI: Offers excellent soft‑tissue contrast without radiation; helpful in complex cases.
• Fistulogram: Injection of contrast through an external opening to outline a fistulous tract.

Laboratory Tests

• Complete blood count (CBC) if infection is suspected.
• Urinalysis & urine culture when urinary symptoms are present.
• For suspected carcinoma: serum carcinoembryonic antigen (CEA) and CA‑19‑9 may be elevated, though not diagnostic.

Pathology

If a cyst or sinus is excised, histopathologic examination confirms the diagnosis and excludes malignancy.

Treatment Options

Management depends on the type of anomaly, symptom severity, and patient age.

Conservative Management

• Observation for small, asymptomatic cysts in infants; many resolve spontaneously.
• Topical antibiotic ointment for mild umbilical dermatitis.

Surgical Intervention

Surgery is the definitive treatment for most symptomatic urachal anomalies.

• Complete Excision (Urachal Resection): Removal of the entire urachal tract, often with a cuff of the anterior bladder wall to prevent recurrence.
• Laparoscopic or Robotic Approaches: Minimally invasive techniques reduce postoperative pain and hospital stay; success rates >95 % in experienced centers [Cleveland Clinic].
• Open Surgery: Reserved for large masses, suspected cancer, or when minimally invasive access is limited.

Management of Infection

• Empiric broad‑spectrum antibiotics (e.g., amoxicillin‑clavulanate) pending culture results.
• Incision and drainage of abscesses if present.
• Definitive surgical excision after the acute infection subsides (usually 4–6 weeks later).

Urachal Carcinoma Treatment

• Surgical resection (partial or radical cystectomy) with en‑bloc removal of the urachus.
• Adjuvant chemotherapy (e.g., 5‑fluorouracil + cisplatin) based on stage.
• Radiation therapy is considered for locally advanced disease.

Lifestyle & Supportive Measures

• Maintain good umbilical hygiene – gentle cleaning with mild soap and drying.
• Promptly treat any skin infections to prevent spread.
• Stay hydrated and practice regular voiding to reduce urinary stasis.

Living with Urachal Anomalies

Even after successful treatment, patients may have concerns about recurrence, activity restrictions, and long‑term health.

• Follow‑up Imaging: Usually a repeat ultrasound or CT 3–6 months post‑surgery, then annually for the first two years.
• Physical Activity: Most patients return to normal activities within 2–4 weeks after minimally invasive surgery. Heavy lifting should be avoided for 6 weeks.
• Scar Care: Use silicone gel sheets or massage to minimize hypertrophic scarring.
• Psychosocial Support: Children may feel self‑conscious about a “belly button scar.” Counseling or support groups can be helpful.
• Monitoring for Cancer: Though rare, anyone with a history of urachal cysts should be alert to new urinary symptoms and report them promptly.

Prevention

Because urachal anomalies are congenital, primary prevention is limited. However, secondary measures can reduce complications:

• Ensure proper prenatal care; maternal diabetes and infections have been linked to a higher rate of congenital anomalies overall.
• Maintain strict umbilical cord care in newborns—keep the stump clean and dry until it falls off naturally.
• Promptly treat any neonatal umbilical infections with appropriate antibiotics.
• Educate parents about signs of a persistent urachus (continuous drainage) so early evaluation can occur.

Complications

If left untreated, urachal anomalies can lead to serious problems:

• Infection/Abscess: The most common complication; may spread to the peritoneum causing peritonitis.
• Umbilical Fistula: Persistent drainage can cause skin irritation, cellulitis, and secondary bacterial infection.
• Urachal Carcinoma: Malignant transformation of a long‑standing cyst or sinus, most often adenocarcinoma.
• Urinary Tract Involvement: Fistulas may communicate with the bladder, leading to recurrent UTIs or urine leakage from the umbilicus.
• Adhesions & Bowel Obstruction: Rarely, a ruptured infected cyst can cause intra‑abdominal adhesions.

When to Seek Emergency Care

Prompt medical attention can prevent life‑threatening infection or complications.

References

1. Mayo Clinic. “Urachal cancer.” https://www.mayoclinic.org. Accessed May 2026.
2. National Center for Biotechnology Information. “Urachal anomalies: review of embryology and clinical presentation.” PMCID: PMC4428525.
3. Cleveland Clinic. “Urachal cyst & fistula – treatment options.” https://my.clevelandclinic.org. Accessed May 2026.
4. World Health Organization. “Management of congenital anomalies: guidelines for health systems.” WHO Press, 2023.
5. U.S. National Cancer Institute. “Urachal carcinoma Treatment (PDQ®) – Health Professional Version.” https://www.cancer.gov.

```